Abstract
Neurofibromin gene (NF1) mutation causes neurofibromatosis type 1 (NF1), a disorder in which brain white matter deficits identified by neuroimaging are common, yet of unknown cellular etiology. In mice, Nf1 loss in adult oligodendrocytes causes myelin decompaction and increases oligodendrocyte nitric oxide (NO) levels. Nitric oxide synthase (NOS) inhibitors rescue this pathology. Whether oligodendrocyte pathology is sufficient to affect brain-wide structure and account for NF1 imaging findings is unknown. Here we show that Nf1 gene inactivation in adult oligodendrocytes (Plp-Nf1 fl/+ mice) results in a motor coordination deficit. Magnetic resonance imaging in awake mice showed that fractional anisotropy is reduced in Plp-Nf1 fl/+ corpus callosum and that interhemispheric functional connectivity in the motor cortex is also reduced, consistent with disrupted myelin integrity. Furthermore, NOS-specific inhibition rescued both measures. These results suggest that oligodendrocyte defects account for aspects of brain dysfunction in NF1 that can be identified by neuroimaging and ameliorated by NOS inhibition.
Keywords
NF1
connectome
oligodendrocytes
resting state
MeSH 主题词
Animals
Brain/cytology,diagnostic imaging,physiopathology
Gene Deletion
Magnetic Resonance Imaging
Mice
Mice, Inbred C57BL
Myelin Sheath/metabolism
Neurofibromin 1/genetics,metabolism
Nitric Oxide/metabolism
Nitric Oxide Synthase/antagonists & inhibitors
Oligodendroglia/metabolism
化学物质
Neurofibromin 1
Nitric Oxide
Nitric Oxide Synthase
作者与单位
共 8 位作者,点击展开单位 / ORCID
Asleh Jad
ORCID
Department of Neuroscience, Rappaport Faculty of Medicine and Institute, Technion-Israel Institute of Technology, 3525422 Haifa, Israel.
Shofty Ben
Department of Neuroscience, Rappaport Faculty of Medicine and Institute, Technion-Israel Institute of Technology, 3525422 Haifa, Israel. | Department of Pediatric Neurosurgery and Gilbert Israeli NF Center, Tel Aviv Medical Center, and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6423906, Israel.
Cohen Nadav
Department of Neuroscience, Rappaport Faculty of Medicine and Institute, Technion-Israel Institute of Technology, 3525422 Haifa, Israel.
Kavushansky Alexandra
Department of Neuroscience, Rappaport Faculty of Medicine and Institute, Technion-Israel Institute of Technology, 3525422 Haifa, Israel.
López-Juárez Alejandro
ORCID
Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH 45229.
Constantini Shlomi
Department of Pediatric Neurosurgery and Gilbert Israeli NF Center, Tel Aviv Medical Center, and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6423906, Israel.
Ratner Nancy
Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH 45229 Nancy.Ratner@cchmc.org kahn@technion.ac.il.
Kahn Itamar
ORCID
Department of Neuroscience, Rappaport Faculty of Medicine and Institute, Technion-Israel Institute of Technology, 3525422 Haifa, Israel; Nancy.Ratner@cchmc.org kahn@technion.ac.il.